- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Elscint's U.S. sales take bigger share
Elscint has shown progressin increasing its position in the U.S. market. Historically, theIsraeli-based medical imaging vendor has been stronger in Europethan in the U.S. With scanner sales sagging in both markets, Elscintviews boosting its U.S. share as
Elscint has shown progressin increasing its position in the U.S. market. Historically, theIsraeli-based medical imaging vendor has been stronger in Europethan in the U.S. With scanner sales sagging in both markets, Elscintviews boosting its U.S. share as an opportunity to maintain itsrevenues.
The vendor saw revenue rise 8% in fiscal 1993 (end-December)to $238 million from $221 million in 1992. However, U.S. saleswere up nearly 50% for the year. Net income rose 7% -- not countingthe $4.8 million positive effect of a change in accounting methods-- from $20 million in 1992 to $21.5 million last year.
